+1 650 843 5528 jraab@cooley.com
Jennifer Raab is a special counsel in Cooley's life sciences practice group, having joined in 2011.
Download full bio
I-Mab Enters Global Strategic Partnership With AbbVie for Cancer Treatment
AveXis – $95 Million IPO
Cour and Takeda Partner to Treat Celiac Disease
Axovant Completes $362 Million IPO
Aduro Completes $137 Million IPO
View all
Life Sciences Corporate Partnering & Licensing
Life Sciences
University of California, Berkeley School of Law (Boalt Hall)JD, 2009
University of California, Los AngelesBS, with departmental honors, Biochemistrydepartmental honors, 2006
I-Mab Enters Global Strategic Partnership With AbbVie for Cancer Treatment September 10, 2020
Jazz Pharmaceuticals Strikes Strategic Collaboration and Option Agreement with ImmunoGen September 12, 2017
Audentes Therapeutics – $85 Million IPO July 29, 2016
California Bar Association
+1 650 843 5528 office +1 650 849 7400 fax jraab@cooley.com
3175 Hanover StreetPalo Alto, CA 94304-1130